Myeloid Cell Surface Antigen CD33

Preferred Label : Myeloid Cell Surface Antigen CD33;

NCIt synonyms : CD33 Antigen; gp67; Siglec-3; Antigen CD33; Sialic Acid-Binding Ig-Like Lectin 3; Sialic Acid-Binding Immunoglobulin-Like Lectin 3; Myeloid Differentiation Antigen CD33;

NCIt related terms : CD33;

NCIt definition : Myeloid cell surface antigen CD33 (364 aa, 40 kDa) is encoded by the human CD33 gene. This protein is involved in the mediation of cell adhesion and the regulation of cell-cell signaling.;

Détails

Origin ID

C97246;

UMLS CUI

C3491277;

Automatic exact mappings (from CISMeF team)
- CD33 [LOINC component]
- CD33 Ag [LOINC component]
- CD33 cells [LOINC component]
- Cd33 antigen [OMIM gene]
- sialic acid binding ig-like lectin 3 [MeSH Descriptor]
- sialic acid binding ig-like lectin 3 [MeSH concept]
OMIM relation
- Cd33 antigen [OMIM gene]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- CD33 protein, human [MeSH concept]
- CD33 protein, human [MeSH Supplementary Concept]
concept_is_in_subset
- CTRP Biomarker Terminology [NCIt concept]
- CTRP Molecular Genetic Biomarker Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- Pediatric Oncology Target Cell Lineage Determinant Terminology [NCIt concept]
gene_encodes_gene_product
- CD33 Gene [NCIt concept]
- Cell Adhesion Molecule Gene [NCIt concept]
- Ligand Binding Protein Gene [NCIt concept]
gene_product_expressed_in_tissue
- Myeloid Cell [NCIt concept]
gene_product_has_associated_anatomy
- Plasma Membrane [NCIt concept]
gene_product_has_chemical_classification
- Immunoglobulin Family Protein [NCIt concept]
gene_product_has_structural_domain_or_motif
- ITIM [NCIt concept]
- Immunoglobulin-Like C2-Type Domain [NCIt concept]
- Immunoglobulin-Like V-Type Domain [NCIt concept]
- Ligand Binding Domain [NCIt concept]
gene_product_is_biomarker_type
- Cluster of Differentiation [NCIt concept]
gene_product_is_element_in_pathway
- Dendritic Cell Pathway [NCIt concept]
- Hematopoietic Cell Lineage Pathway [NCIt concept]
gene_product_plays_role_in_biological_process
- Cell Adhesion Process [NCIt concept]
- Intercellular Communication Process [NCIt concept]
- Ligand Binding [NCIt concept]
is_target
- Actinium Ac 225-FPI-1434 [NCIt concept]
- Allogeneic Anti-CD33 CAR NK Cells [NCIt concept]
- Allogeneic Anti-CD33 CAR T-cells VCAR33 [NCIt concept]
- Allogeneic Anti-CD33 CAR-NK Cells QN-023a [NCIt concept]
- Allogeneic CD33CAR-CD3zeta-4-1BB-expressing T-lymphocytes [NCIt concept]
- Allogeneic Calibrated Release IL-15-expressing Logic-Gated Gene Circuit Anti-CD33/FLT3 CAR-NK Cells SENTI-202 [NCIt concept]
- Anti-CD16/IL-15/Anti-CD33 Trispecific Natural Killer Cell Engager GTB-3650 [NCIt concept]
- Anti-CD33 Antibody-drug Conjugate BL-M11D1 [NCIt concept]
- Anti-CD33 Antibody-drug Conjugate IMGN779 [NCIt concept]
- Anti-CD33 CAR T-cells [NCIt concept]
- Anti-CD33 GSPT1 Degrader BMS-986497 [NCIt concept]
- Anti-CD33 Monoclonal Antibody BI 836858 [NCIt concept]
- Anti-CD33/BET Degrader ADC ABBV-787 [NCIt concept]
- Anti-CD33/CD123/CD70 DARPin CD3 Engager MP0533 [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody JNJ-67571244 [NCIt concept]
- Anti-CLL1/Anti-CD33 CAR-T Cells LCAR-AMDR [NCIt concept]
- Autologous Anti-CD33 CAR-mbIL15-Safety Switch T-cells PRGN-3006 [NCIt concept]
- Autologous CLL1-CD33 Compound CAR T Cells [NCIt concept]
- CD123-CD33 Compound CAR T Cells [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Allogeneic T-lymphocytes [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- CD33CAR-CD3zeta-4-1BB-expressing Autologous T-Lymphocytes [NCIt concept]
- Dimerizing Agent Regulated Immunoreceptor Complex-expressing CD33-specific Autologous CAR T Cells SC-DARIC33 [NCIt concept]
- Eluvixtamab [NCIt concept]
- Emerfetamab [NCIt concept]
- Gemtuzumab Ozogamicin [NCIt concept]
- Lintuzumab [NCIt concept]
- Vadastuximab Talirine [NCIt concept]
- Vixtimotamab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients